Loading clinical trials...
Loading clinical trials...
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Conditions
Interventions
KRX-0502
Locations
28
United States
Arizona Kidney Disease and Hypertension center: AKDHC Medical Research Services, LLC
Phoenix, Arizona, United States
California Institute of Renal Research
Chula Vista, California, United States
California Institute of Renal Research
El Centro, California, United States
California Institute of Renal Research
Poway, California, United States
Denver Nephrologists, P.C.
Denver, Colorado, United States
Miami Kidney Group
Miami, Florida, United States
Start Date
August 15, 2017
Primary Completion Date
August 30, 2019
Completion Date
September 27, 2019
Last Updated
March 12, 2021
NCT06337838
NCT05318196
NCT05728216
NCT06578078
NCT04592640
NCT07094906
Lead Sponsor
Keryx Biopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions